ImmunoCellular Therapeutics, Ltd. announced that on April 14, 2015, Richard Chin notified the Nominating and Corporate Governance Committee of the company that he will not stand for re-election as a director at the company's 2015 Annual Meeting of Stockholders. Dr. Chin will remain a director until the Annual Meeting and has no disagreements with the company relating to it's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.199 USD | 0.00% | 0.00% | -14.22% |
1st Jan change | Capi. | |
---|---|---|
-14.22% | 22.54M | |
+49.41% | 56.95B | |
+40.15% | 40.26B | |
-6.72% | 39.32B | |
-5.96% | 28.37B | |
+12.99% | 26.45B | |
-19.82% | 19.41B | |
+32.35% | 12.54B | |
-0.08% | 12.15B | |
+25.18% | 12.21B |
- Stock Market
- Equities
- IMUC Stock
- News EOM Pharmaceuticals Holdings, Inc.
- Richard Chin Not to Stand for Re-Election as Director of Immunocellular Therapeutics, Ltd